Rapamycin Holdings, Inc. — Form D
Rapamycin Holdings, Inc. of SAN ANTONIO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-16. The offering totals $1.5M. Industry: Pharmaceuticals.
Offering
- Filed: 2018-02-16
- Form: D
- Accession: 0001582949-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $1.5M
- Remaining: $1.5M
- Minimum investment: $100K
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-305892
Issuer
- Name: Rapamycin Holdings, Inc.
- CIK: 0001582949
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 16601 BLANCO RD. SUITE #120, SAN ANTONIO, TX, 78232
- Phone: 210-381-2486
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Hargrove Dan | Executive Officer | Austin, TX |
| Mark Horsey | Executive Officer | San Antonio, TX |
| Stephen Dufilho | Director | San Antonio, TX |
| Spangler Vaughn Carole | Executive Officer | San Antonio, TX |
| Randy H Goldsmith | Director | Austin, TX |
| Randy H Goldsmith | Executive Officer | Austin, TX |
| Stephen H Dufilho | Director | San Antonio, TX |
| Mark H Horsey | Executive Officer | San Antonio, TX |
Other filings by this issuer (6)
More